Stockwinners Market Radar for December 28, 2023 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

19:50 EST Avalo Therapeutics trading halted, news pending

17:50 EST Four Corners Property Trust acquires two Popeye properties for $4.7M - Four Corners Property Trust "announces the acquisition of two Popeyes properties for $4.7 million. The properties are located in strong retail corridors in Arizona and Illinois and are occupied under a long-term, triple net lease with approximately 20 years of term remaining. The properties are in the final stages of construction but rent will commence immediately at close. The transaction was priced at a cap rate in range with previous FCPT transactions."

17:12 EST Lockheed Martin awarded $107.48M Navy contract order - Lockheed Martin was awarded a not-to-exceed $107.48M, undefinitized, cost-plus-fixed-fee modification to an order against a previously issued basic ordering agreement. This modification adds scope to provide for the development, test and integration of the U.S. and exportable cross domain solution, interim and final components, as well as inline file encryption devices and associated systems engineering to develop mission planning enterprise country kit requirements for the F-35 NextGen Mission Planning Enterprise Software, in support of the Joint Strike Fighter Program for the Navy, Air Force, Marine Corp, Foreign Military Sales customers, and non-U.S. Department of Defense, or DOD, participants. Work is expected to be completed in July 2028. FY24 research, development, test and evaluation funds in the amount of $2.25M FY24 research, development, test and evaluation funds in the amount of $2.25M and non-U.S. DOD participant funds in the amount of $1M, will be obligated at the time of award, none of which will expire at the end of the current fiscal year. Naval Air Systems Command is the contracting activity.

16:44 EST Annexon director buys $1.0M in common stock - In a regulatory filing, Annexon disclosed that its director Muneer Satter bought 350K shares of common stock on December 26th in a total transaction size of $1.0M. Shares are up 5.5% at $4.82 afterhours.

16:22 EST FedEx CFO buys $252K in common stock - In a regulatory filing, FedEx disclosed that its CFO John Dietrich bought 1K shares of common stock on December 28th in a total transaction size of $252K.

16:18 EST Kadant acquires Key Knife for $156M in cash - Kadant has entered into a definitive agreement to acquire Key Knife, Inc. and certain of its affiliates for approximately $156M in cash, subject to certain customary adjustments. The acquisition is expected to close in early January 2024, subject to the satisfaction of customary closing conditions, and will be financed primarily through borrowings under Kadant's revolving credit facility. Founded in 1986, Key Knife is a global supplier of engineered knife systems for custom chipping, planing, and flaking solutions for wood product industries.

16:17 EST Globant acquires Iteris Holding Ltda - Globant "announced the acquisition of Iteris Holding Ltda., a Brazilian business and technology consultancy focused on delivering digital transformation. This acquisition enhances Globant's current operations in Brazil by adding top local digital capabilities and an impressive client roster. Founded in 2009 in Sao Paulo, the Iteris team includes over 600 top professionals that develop end-to-end solutions across several industries, such as payments & banking, manufacturing, communications, education, retail, and healthcare for some of the strongest brands in Brazil, such as Fiserv, PagBank, Julius Baer, Nubank, Nutrien, Globo, C&A, Reckitt, and Heineken, among others."

16:12 EST Onconetix discloses Chief Business Officer resigns - In a regulatory filing, Onconetix disclosed that on and effective December 21, Erin Henderson resigned as Chief Business Officer of the company to pursue other opportunities. "The company and Ms. Henderson are in the process of finalizing the terms of a Separation Agreement and a Consulting Agreement, pursuant to which Ms. Henderson will serve as a consultant to the company for three months," the filing noted. Reference Link

16:08 EST Kinder Morgan closes on $1.815B purchase of NextEra Partners' South Texas assets - Kinder Morgan (KMI) has closed on its previously announced $1.815B acquisition of NextEra Energy Partners' (NEP) South Texas assets, which includes a set of integrated, large diameter high pressure natural gas pipeline systems that connect the Eagle Ford basin to key growing Mexico and Gulf Coast demand markets. The acquisition includes a 90% interest in the NET Mexico pipeline, Eagle Ford Midstream and a 50% interest in Dos Caminos - Howard Energy Partners owns the remaining 50% and will continue to operate the pipeline. Dos Caminos recently placed in service a 62-mile pipeline connecting HEP's existing midstream pipeline and facilities in Webb County, Texas to KMI's new Eagle Ford pipeline, which was placed in service on November 1, 2023. This portfolio of assets is highly contracted, with an average contract length of over 8 years. Approximately 75% of the business is supported by take-or-pay contracts. KMI expects the acquisition to be accretive to its preliminary 2024 budget guidance with the purchase price equal to 8.6 times the 2024 EBITDA and a long-term investment-to-EBITDA multiple of approximately 7.0-7.5 times, inclusive of commercial synergies. Initially, we plan to fund the transaction with cash on hand and short-term borrowings, increasing our expected Net Debt-to-Adjusted EBITDA ratio for 2024 by approximately 0.1 times after including a full year Adjusted EBITDA contribution from the asset. "We are pleased to add these assets to our natural gas portfolio to serve growing LNG, industrial, Mexico export and power generation demand markets on the U.S. Gulf Coast. These assets integrate well with our existing South Texas footprint and extend our direct connectivity in the lean area of the Eagle Ford Basin, allowing us to offer LNG customers greater access to desirable low-nitrogen natural gas supply," said KMI President of Natural Gas Pipelines Sital Mody.

16:06 EST Allied Gaming & Entertainment announces investment from Elite Fun Entertainment - Allied Gaming & Entertainment announced that Elite Fun Entertainment Co. Ltd., a premier player in the Macau cultural and entertainment industry, has agreed to a strategic investment in AGAE. On December 28, 2023, Elite Fun Entertainment Co., Ltd. agreed to acquire 7,330,000 shares of Allied Gaming & Entertainment's common stock at a purchase price of $0.90 per share for a total purchase price of $6,597,000. In addition, the parties have agreed to negotiate and finalize a collaboration or partnership agreement under which Elite Fun Entertainment Co., Ltd. will assist the Company with organizing live shows and events in Asia.

16:03 EST Boston Scientific now anticipates FDA approval of FARAPULSE PFA System in Q1 - Boston Scientific announced it has initiated the AVANT GUARD clinical trial to evaluate the safety and effectiveness of the FARAPULSE Pulsed Field Ablation, or PFA, System as a first-line treatment for persistent atrial fibrillation, or AF, noting it is "the only trial to study the use of PFA as frontline therapy in patients with this form of AF." Outcomes of ablation with the FARAPULSE PFA System - a nonthermal treatment in which electric fields selectively ablate heart tissue - will be compared to outcomes following use of anti-arrhythmic drug therapy, which is commonly prescribed for patients living with persistent AF. This week, the Cleveland Clinic enrolled the first patient in the AVANT GUARD trial, overseen by Dr. Oussama Wazni, vice chair of cardiovascular medicine and section head, Cardiac Electrophysiology and Pacing, Cleveland Clinic, who is also serving as the lead investigator of the trial. Earlier this year, clinical trial data presented demonstrated the FARAPULSE PFA System is noninferior to standard-of-care therapies for the treatment of paroxysmal AF, with superior efficiency, while additional real-world data from more than 17,000 patients demonstrated continued real-world safety, efficacy and efficiency of the system. Boston Scientific also completed enrollment in the first phase of the ADVANTAGE AF clinical trial in the third quarter of 2023, which is studying the system for the treatment of patients with drug refractory symptomatic persistent AF, and commenced enrollment in an extension arm of the study to evaluate the safety and effectiveness of adjunctive use of the FARAPOINT PFA Catheter for cavotricuspid isthmus ablations, a procedure used to treat atrial flutter. The company now anticipates U.S. Food and Drug Administration approval of the FARAPULSE PFA System in the first quarter of 2024.

15:31 EST Gold Fields falls over 10% after cutting production volumes, personnel issues - Earlier on Thursdsay, global gold producer Gold Fields Limited (GFI) announced an update to production of first gold from its Salares Norte Project in Chile, which has been impacted by delays in pre-commissioning and commissioning activities. First gold from the Project is now expected by April 2024 and production volumes for 2024 have been revised down and are expected to fall within a range of 220,000 - 250,000 gold-equivalent ounces. Monthly steady state production is expected to be reached by the beginning of 2025 and therefore planned production volumes for 2025 and 2026 are not expected to be affected and remain unchanged at 600,000 gold-equivalent ounces each year....Gold Fields had anticipated first gold from the project in Chile's Atacama region by December 2023, but this has had to be pushed out due to a number of factors including: Recent delays to the pre-commissioning process due to rework required on critical safety aspects relating to the cyanide circuit and other reagent circuits. This has had a knock-on effect on the pre-commissioning and commissioning processes. Personnel availability for the primary contractor at the project.Shares of Gold Fields are down $1.65 per share in late day trading to $14.50 per share. Other mining companies in Chile include: Anglo American (NGLOY), Antofagasta (ANFGF), Teck Resources (TECK), Barrick Gold (GOLD), and Freeport-McMoRan (FCX). Reference Link

15:04 EST Innovative International Aqstn Corp trading halted, volatility trading pause

14:40 EST BIO-key and Evolutio team on Carrefour intergration of AuthControl in Spain - BIO-key International (BKYI) announced that Carrefour (CRRFY) is integrating BIO-key's AuthControl Sentry cloud solution in Spain in collaboration with Evolutio, a trusted partner of BIO-key's Swivel Secure Europe subsidiary. The strategic collaboration is part of Carrefour's ongoing commitment to operational excellence and data security. AuthControl Sentry is now a key component in safeguarding the authentication process for Carrefour's 6,500 Spanish employees. The solution protects access to critical services and reinforces the company's dedication to the highest standards of data security and privacy. Alex Rocha, Managing Director of BIO-key Europe, commented, "We are honored to have leading global retailer Carrefour implement our AuthControl Cloud Sentry solution in Spain. This collaboration, facilitated by our partner Evolutio, showcases the security, versatility and reliability of our products in meeting the complex cybersecurity needs of large-scale organizations. BIO-key Europe is committed to delivering top-tier security solutions that empower businesses like Carrefour to operate with confidence and resilience in an increasingly digital world. Our AuthControl solution not only enhances operational efficiency but also ensures the utmost security for our customers, their employees and critical data."

13:24 EST Pendragon says approval received from FCA for Lithia deal - In a notice to the London Stock Exchange, Pendragon (PDGNF) stated: "Pendragon is pleased to announce that the FCA Conditions have now been satisfied after both Pendragon and Lithia received approval from the FCA for the change of control of Pendragon Finance and Insurance Services Limited. As a result, and in accordance with the terms of the Sale Agreement, the completion date for the sale of the entire issued share capital of Pendragon NewCo 2 Limited, the entity that holds, either directly or indirectly through its wholly-owned subsidiaries, Pendragon's UK motor business (sale and servicing of vehicles in the UK) and leasing business (fleet and contract hire provider and used vehicle supply), to Lithia is expected to take place, following the satisfaction of the remaining customary completion conditions, on 31 January 2024 alongside the completion of the Subscription to Lithia and entry into the Strategic Partnership with a wholly-owned subsidiary of Lithia Motors, Inc.. Completion of the Transaction will mark the beginning of the transformation of Pendragon into Pinewood Technologies, a pure-play SaaS business, which operates the Company's dealer management software business. The Board strongly believes that the growth prospects for the Company will be enhanced materially as a result of becoming a standalone business, as well as through the Strategic Partnership with Lithia."

12:32 EST First Wave BioPharma Inc trading resumes

12:00 EST Sunlands Online rises 12.0% - Sunlands Online is up 12.0%, or $1.09 to $10.10.

12:00 EST Amprius Technologies rises 20.0% - Amprius Technologies is up 20.0%, or 96c to $5.75.

12:00 EST SOS Limited falls -10.1% - SOS Limited is down -10.1%, or -68c to $6.07.

10:29 EST Banyan Acquisition Corp trading resumes

10:24 EST Banyan Acquisition Corp trading halted, volatility trading pause

10:00 EST Park Hotels & Resorts falls -4.7% - Park Hotels & Resorts is down -4.7%, or -77c to $15.57.

10:00 EST Wheels Up falls -8.7% - Wheels Up is down -8.7%, or -50c to $5.24.

10:00 EST Amprius Technologies rises 12.5% - Amprius Technologies is up 12.5%, or 60c to $5.39.

09:52 EST Knightscope announces contract for K5 ASR from real estate investment firm - Knightscope announces a new contract for its 5th Generation K5 Autonomous Security Robot from a privately owned, Miami-based real estate investment company. The K5 ASR will patrol a retail shopping center in Kansas City, Missouri.

09:47 EST Unifi rises 7.1% - Unifi is up 7.1%, or 44c to $6.61.

09:47 EST Altice USA rises 7.9% - Altice USA is up 7.9%, or 24c to $3.29.

09:47 EST ProShares UltraShort Bloomberg Natural Gas falls -4.8% - ProShares UltraShort Bloomberg Natural Gas is down -4.8%, or -$4.80 to $94.80.

09:42 EST Bridger Aerospace Group Holdings Inc trading resumes

09:37 EST Bridger Aerospace Group Holdings Inc trading halted, volatility trading pause

09:18 EST Apple Hospitality REIT acquires SpringHill Suites in Las Vegas for $75M - Apple Hospitality REIT announced the acquisition of the 299-room SpringHill Suites by Marriott Las Vegas Convention Center for approximately $75M, or $251,000 per key. The SpringHill Suites Las Vegas Convention center opened in October 2009 and is located at 2989 Paradise Road, Las Vegas, Nevada. Adjacent to the newly expanded Las Vegas Convention Center, the Hotel features amenities including spacious guest rooms, more than 10,000 square feet of flexible indoor and outdoor meeting space, a rooftop pool with views of the Las Vegas Strip, and a seven-story parking garage and surface lot with a combined total of 244 spaces. The surface lot is zoned and master planned for future development of additional hotel rooms. There are many conditions to closing on each of these hotels that have not yet been satisfied, and there can be no assurance that closings on these hotels will occur under the outstanding purchase contracts.

09:09 EST ZK International Group shares corporate update on recent developments - ZK International Group shares a corporate update highlighting recent developments and the launch of its new website. In a move to provide a more engaging and informative experience, ZK International unveils its redesigned website. This user-friendly platform showcases the core businesses, diverse product portfolio, highlights key projects, and serves as a dynamic hub for the latest industry insights on the Company. ZK International recently achieved a significant milestone by securing a $8 million bid in collaboration with Chongqing Gas Group. This success is a testament to our commitment to excellence, quality, and customer satisfaction, reinforcing our competitive edge in the Western China Gas Market. In a move to capitalize on our market momentum, ZK International has successfully closed a $5 million financing above the market. In addition, ZK International Group is pleased to announce that it is Nasdaq compliant, having successfully resolved the bid price deficiency concern. The Nasdaq Listing Qualifications staff has confirmed the company's compliance with all applicable listing standards.

09:07 EST Great Lakes Dredge receives $173.7M in awarded work - Great Lakes Dredge & Dock announced the receipt of several dredging awards totaling $173.7M. The awarded work includes: Sabine-Neches Waterway Channel Improvement Project-Phase 1; Great Egg Harbor Inlet Beach Renourishment Project; St. Augustine Shore Protection Project; Duval County Shore Protection Beach Renourishment Project; Atchafalaya Bay and Bar Maintenance Dredging Project.

09:03 EST NeuroBo submits IND application to FDA for Phase 1 trial of DA-1726 - NeuroBo Pharmaceuticals announced that it has submitted an Investigational New Drug, IND, application to the U.S. Food and Drug Administration, FDA. The IND application supports a Phase 1 clinical trial of DA-1726, a novel, dual oxyntomodulin analog agonist that functions as a glucagon-like peptide-1 receptor, GLP1R, and glucagon receptor for the treatment of obesity. "Filing of the IND for DA-1726 is as a seminal event in the development of this GLP-1 and glucagon dual receptor, bringing it one step closer to the clinic as a potential new treatment to address the significant obesity market," stated Hyung Heon Kim, President and Chief Executive Officer of NeuroBo. "Preclinical evidence shows that DA-1726 reduced food intake while also increasing energy expenditure, which resulted in persistent weight loss in diet-induced obese mice and rats. Importantly, in mouse models, DA-1726 showed superior weight loss compared to semaglutide. Additionally, the administration of DA-1726 resulted in similar weight reduction while consuming more food compared to tirzepatide. It is our belief that DA-1726's balanced activation between GLP-1 and glucagon receptors, may lead to better glycemic control and may have a better tolerability profile than current GLP-1 agonists. We look forward to initiating the clinical development for DA-1726, with the first dose expected to be administered in the first half of 2024 and an expected data readout in the first half of 2025."

09:02 EST LM Funding sells Symbiont's blockchain technology to Platonic Holdings - LM Funding has signed an agreement to sell Symbiont's blockchain technology for $2M to Platonic Holdings. $200K of the sale price will be held in escrow until December 26, 2024. LM Funding acquired the assets of Symbiont.IO as debtor in possession in its Chapter 11 bankruptcy case and they are recorded on the company's books for $2M. The company closed the deal on December 27, 2023.

08:58 EST BriaCell reports 71% CNS response rate in advanced breast cancer patients - BriaCell Therapeutics reports marked 71% intracranial objective response rate in advanced breast cancer patients suffering from central nervous system metastases and treated with BriaCell's Bria-IMT regimen. iORR is defined as the percentage of patients who achieve either a complete response or partial response in intracranial tumors. Breast cancer metastasis to the CNS presents a significant clinical challenge, often leading to poor prognosis and early death. BriaCell has recently conducted a retrospective analysis in breast cancer patients with CNS metastases enrolled across both its Bria-IMT monotherapy and combination therapy with CPI studies and found remarkable clinical responses. BriaCell Clinical Data in Advanced Metastatic Breast Cancer Patients with CNS Metastases Yhe Bria-IMT Regimen: CNS lesions improved in 71% of patients, supporting clinical efficacy of the Bria-IMT regimen; Findings provide evidence for the efficacy of the Bria-IMT regimen, both alone and in combination with CPI, in CNS metastases patients; Heavily pretreated metastatic breast cancer patients had failed multiple prior treatments including one patient who had failed treatments with 2 antibody-drug conjugates; Regression of CNS metastatic tumors was observed across all breast cancer subtypes in heavily pretreated patients highlighting the potential of the Bria-IMT regimen in managing CNS metastases; BriaCell is adding a pre-planned subgroup analysis of patients with CNS metastases to its pivotal Phase 3 study in advanced metastatic breast cancer patients. This could provide an additional indication for market approval of Bria-IMT.

08:51 EST Modaxo to acquire Curbside Management, Public Safety businesses from Conduent - Constellation Software Inc. (CNSWF) announced that its People Transportation Division operating as Modaxo, has signed an agreement to acquire the Curbside Management and Public Safety Businesses from Conduent Incorporated (CNDT). Completion of the acquisition remains subject to closing conditions. Conduent's Curbside Management business provides parking management systems to the public sector, while their Public Safety business provides traffic management solutions such as automated photo enforcement for speed and red-light violations processing to its government clients.

08:44 EST Moderna exec sells $4.5M in common stock - In a regulatory filing, Moderna disclosed that its president Stephen Hoge sold 45K shares of common stock on December 27th in a total transaction size of $4.5M.

08:38 EST Chart Industries receives multiple LNG-related awards - Chart Industries announced the recent receipt of multiple LNG-related awards, including: IPSMR liquefaction technology for two modular trains of a multi-train international Big LNG project; IPSMR liquefaction technology for a mid-scale plant in Asia Pacific; North American small-scale LNG nitrogen cycle technology and associated equipment; various LNG infrastructure related orders, including tanks, fueling stations in Europe, and Morocco's first LNG regasification units; Repair and service work at a Middle East LNG project.

08:37 EST Foremost Lithium announces drilling plans on Zoro Lithium property - Foremost Lithium Resource & Technology announced its drilling plans on its Zoro Lithium Property located near the historic mining centre of Snow Lake in Manitoba. The Company is completing plans in preparation of 30-hole, 7,500-metre diamond drill winter program including submitting work permits at the Manitoba Mines Branch. The drill program on the Zoro Property will be in addition to the Company's recently announced 2,500 metre diamond drill program on its Jean Lake Lithium/Gold Property located in the same mining centre. Drilling on both properties will total 10,000 metres. Foremost Lithium's Zoro and Jean Lake Properties share contiguous borders with Snow Lake Lithium's Thompson Brothers and Grass River properties, which are disclosed as having an aggregate measured, indicated and inferred resource estimate of approximately 8.2 million tonnes of 1% Li2O. The Zoro Property is directly adjacent to the Thompson Brother's lithium trend, known for hosting several lithium enriched occurrences. The Zoro Property is also adjacent to the Crowduck Bay Fault which is a significant regional focus for the development of lithium-enriched pegmatite clusters. Jason Barnard, Chief Executive Officer and President of Foremost Lithium, comments: "This is the most aggressive drill program our company has embarked on to date. With the most recent announcement of drilling on our Jean Lake Lithium/Gold Property, we will be running two winter drill programs on two different projects for a combined 10,000 metres of drilling this winter. We are pleased to be working our first drill program with Dahrouge and feel confident that we will be able to optimize our resource potential on both our Zoro and Jean Lake Properties to increase shareholder value."

08:35 EST Smith-Midland Corp appoints Read Van de Water, Matthew Smith to board - Smith-Midland Corporation has appointed Ms. Read Van de Water and Mr. Matthew Smith to its Board of Directors. Ms. Van de Water was elected as the Chairman of the Nominating and Governance Committee. Van de Water is the Senior Vice President, External Affairs at Safran USA. Matthew Smith is the Vice President of Sales & Marketing at Smith-Midland and the President of Concrete Safety Systems. Van de Water will be replacing long-term board member Mr. Wesley A. Taylor who announced his retirement upon the appointment of Ms. Van de Water.

08:32 EST SeaStar Medical enrolls 12 subjects in NEUTRALIZE-AKI trial - SeaStar Medical Holding announces enrollment of 12 subjects in the NEUTRALIZE-AKI pivotal clinical trial evaluating the safety and efficacy of its patented, first-in-class, cell-directed Selective Cytopheretic Device extracorporeal therapy in critically ill adults with acute kidney injury requiring continuous kidney replacement therapy. SeaStar Medical expects to receive U.S. Food & Drug Administration approval for its SCD Pediatric under a Humanitarian Device Exemption for use in children weighing 10 kilograms or more with AKI and sepsis or a septic condition requiring continuous CKRT anytime within the next 30 to 45 days and to commence commercialization of the SCD-PED in Q1 2024.

08:14 EST Metals Company subsidiary completes offshore research campaign - Metals Company, or TMC, concluded its latest offshore scientific research campaign to assess seafloor impacts and recovery rates twelve months after the pilot nodule collection system test conducted by its Nauru Ocean Resources - NORI . subsidiary. Despite disruptions from Greenpeace International aimed at hindering the collection of key environmental data requested by the ISA's Legal and Technical Commission, researchers were able to complete the major components of the scientific work scope slated for the campaign. The data gathered will further support NORI's application to the International Seabed Authority for a commercial exploitation contract, which it expects to submit following the July 2024 meeting of the ISA. Earlier this month, NORI began sharing emerging data on the characteristics of seafloor sediment plumes. In line with its commitment to share this environmental data with society, NORI also convened a global stakeholder webinar to provide an update on its environmental program.

08:12 EST HG Vora confirms asking Penn Entertainment for seats on board - In a regulatory filing, HG Vora Capital Management disclosed that they hold the economic equivalent of an 18.5% position in Penn Entertainment's common stock, consisting of beneficial ownership of 14.5M shares of the company's outstanding common stock and a cash-settled swap agreement representing economic exposure to an additional 13.5M shares of common stock, plus other cash-settled options. "The Reporting Persons have deep experience investing in the casino and online gaming sectors, are long-term shareholders of the Issuer, and believe the Issuer's Common Stock is significantly undervalued. The Reporting Persons have discussed with the Issuer's management and its board of directors a range of topics focused on enhancing shareholder value. Given the persistent underperformance of the Common Stock and the Issuer's capital allocation track record, amongst other areas of concern, the Reporting Persons have requested that the Issuer afford them the right to designate highly qualified directors who would be committed to working with the Issuer's management and fellow Board members to help the Issuer realize its full potential," the firm stated in its filing. In pre-market trading, Penn shares are up 52c, or 2%, to $25.53. Reference Link

08:10 EST SinglePoint lists on CBOE, adds Tony Thomas to board - SinglePoint announce the appointment of Tony Thomas to its Board of Directors. Thomas serves as a Managing Director and Head of the financial advisory and asset management practice of Harbor Bankshares Capital Corporation.

08:08 EST TeraWulf reports fully funded 7.9 EH/s mining capacity, future expansion plans - TeraWulf provided a business update. Highlights include: fully funded 7.9 EH/s expansion, increasing self-mining capacity by 58%; Building 3 at the Lake Mariner facility is operational and ready for delivery, installation and energization of new miners; estimated deployment date of February 1, 2024, for all 18,500 BITMAIN Antminer S19j XP bitcoin miners; additional growth underway at the Lake Mariner facility with the foundation of Building 4 poured and construction ongoing, which, upon completion in mid-2024, will bring TeraWulf's total operational capacity to ~10 EH/s; expansion of existing high-performance computing project supporting generative AI and large language model applications at the Lake Mariner facility, planned for 2024;

08:06 EST Bionano Genomics upgrades optical genome mapping pipeline - Bionano Genomics announced upgrades to its pipeline for analysis of optical genome mapping - OGM - data in its VIA software for applications in constitutional genetic disease. The latest analysis pipeline, Bionano Solve 3.8.1, enhances the sensitivity and specificity for structural variation - SV - detection from OGM data, which, when combined with copy number variant - CNV - analysis capabilities introduced in July 2023, further advance OGM's variant detection. Together with the enhanced performance for SV and CNV calling, VIA software now enables visualization, interpretation and reporting of SVs and CNVs from OGM data. Researchers can construct a report template with desired sample and variant information that is relevant for a particular study. Reports can then be automatically populated for each sample during the course of a research study. VIA software contains a knowledge base, which consists of a vault of previously curated variant interpretations. VIA software enables the integration of multiple data types, including chromosomal microarray analysis and next-generation sequencing, which can be visualized, interpreted and reported alongside OGM.

08:04 EST Sinnet Capital Partners issues letter to Franklin Wireless' board of directors - Sinnet Capital Partners, along with Managing Partner Timothy Hasara, collectively own 380,000 shares or 3.2% of the outstanding shares of Franklin Wireless and issued the following public letter to the Company's Board of Directors: "Franklin Wireless has generated cash over time, and specifically since the beginning of Covid. The cash has grown from $12.9 million in March 2020, at the beginning of the pandemic, to $33.6 million at the end of the most recent quarter, ending September 2023. However, the stock performance is basically unchanged since this period of time! Franklin Wireless has no debt and approximately $2.86 per share in cash. Shareholders should be rewarded with this cash generation - returned in the form of a special dividend and stock buyback. Sinnet Capital Partners recommends the Board of Directors take the following actions: The company pays a special dividend of $1.00 per share. The company executes a $10 million Dutch tender buyback of the stock. The company hires an IR firm to issue Press Releases for significant events and earnings filings. Franklin Wireless has had a number of great accomplishments over the last 12 months. However, investors have to reach far and wide to find out about these achievements. The company has been awarded four contracts since last December that Sinnet Capital believes were significant, but they did not issue a Press Release in any of the national news services utilized by most investors... Franklin Wireless did issue Press Releases on a national news service in the past, GlobeNewswire, but stopped doing so in 2021. The stock closed the end of 2022 at $4.46 per share and the stock closed at $3.03 on December 22, 2023. Sinnet Capital believes the stock has not performed well over the last year, down primarily as the result of the company not issuing Press Releases regarding their contract announcements and earnings. Sinnet Capital urges the board to pay a $1 special dividend, execute a $10 million dollar Dutch tender buyback and hire an IR firm to issue Press Releases."

08:03 EST Synchronoss regains compliance with Nasdaq minimum bid price rule - Synchronoss Technologies has received notice from The Nasdaq Stock Market informing the Company that, after having a closing bid price over $1.00 for over eleven consecutive business days from December 11 through December 26, it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market, and that matter is now closed.

08:01 EST ViaSat awarded up to $900M from U.S. Air Force - Viasat announced it will work with the U.S. Air Force's Life Cycle Management Center, USAF LCMC, to transition and integrate new innovative technologies and capabilities as part of a $900 million ceiling, Indefinite Delivery/Indefinite Quantity, IDIQ, contract. Under the multi-award contract - known by its initialism LCMC XA IDIQ - Viasat is expected to prototype and test systems, hardware, software, and cybersecurity solutions to provide integrated, multi-domain capabilities for the USAF. Viasat experts will accelerate and expand technology integration across the Air Force. The contract has an approximate five-year term, with options for up to an additional five years. "Resilient communications and communications security are critical for military operations, and the USAF has been clear they need to move technology from development to at-scale operational use quicker than ever," said Susan Miller, President of Viasat Government. "This award provides the means to work directly with the Air Force research, development and operational communities to transition a huge range of developments, which can all ultimately help deliver mission success."

07:35 EST The Real Brokerage named as defendent in class action alleging antitrust fault - The Real Brokerage announced that it has been named as a defendant in a putative class action lawsuit, which was filed in the United States District Court for the Western District of Missouri. The lawsuit, under the caption Umpa v. The National Association of Realtors, et al. alleges that certain real estate brokerages, including The Real Brokerage, participated in practices resulting in inflated buyer broker commissions, in violation of federal antitrust laws.

07:34 EST Revival Gold reviews 2023 accomplishments for Beartrack-Arnett - Revival Gold provides a review of key accomplishments this year to advance the Company's Beartrack-Arnett Gold Project located in Idaho, USA. Highlights: Increased Measured and Indicated Mineral Resources to 86.2 million tonnes grading 0.87 g/t gold containing 2.42 million ounces of gold and Inferred Mineral Resources to 50.7 million tonnes grading 1.34 g/t gold containing 2.19 million ounces of gold. Notably, Open pit heap leach Measured and Indicated Resources increased to 42.3 million tonnes grading 0.70 g/t gold containing 959,000 ounces of gold with additional Inferred Resources of 6.3 million tonnes grading 0.53 g/t gold containing 108,000 ounces of gold; and, Underground mill Inferred Resources increased to 6.7 million tonnes grading 4.0 g/t gold containing 877,000 ounces of gold. Filed a Preliminary Feasibility Study on the potential first phase restart of open pit heap leach operations: Inaugural Proven & Probable open pit heap leach Mineral Reserve of 36.2 million tonnes grading 0.74 g/t gold for 859,000 ounces of gold; Average gold production of 65,300 ounces of gold per year, for a total of 529,100 ounces of gold over an eight-year mine life; and, After-tax NPV at a 5% discount rate of $105 million and after-tax IRR of 24.3% at $1,800 per ounce gold increasing to an NPV5% of $138 million and after-tax IRR of 29.5% at $1,900 per ounce gold1 Continued to advance conceptual plans for a potential second phase underground operation by completing a third stage of metallurgical testing demonstrating gold recoveries of 93% to concentrate from a composite of high-grade sulphide material in the underground resource achieving a concentrate grade of 50 g/t gold with a relatively coarse particle grind size of 150 mum and a resulting mass pull of 8.9%. Completed a total of eighteen core holes for 3,350 meters of exploration drilling focused on near-surface oxide gold opportunities in the broader Haidee area. Results included 3.93 g/t gold over 20.6 meters3 in a potential feeder structure on the western flank of Haidee. Three of the four targets drilled this year were previously untested by Revival Gold and all three yielded above cut-off grade results in near-surface oxide mineralization including 0.37 g/t gold over 22.6 meters4 and 0.36 g/t gold over 9.0 meters4 at the Ridge and Midlands targets, respectively. The Company raised C$9.4 million in equity funding and re-acquired a 1% Net Smelter Royalty on sixteen claims within the Beartrack-Arnett project area. Added to Revival Gold's operating and exploration expertise and capabilities with the addition of Larry Radford to the Company's Board of Directors and the hiring of Dan Pace as Chief Geologist. Maintained an exemplary safety record with zero lost-time incidents among Company employees and contractors.

07:23 EST Wearable Devices signs agreement with golobal defense company - Wearable Devices has signed an agreement with a global leading defense company, to design together a first of its kind prototype for defense use cases. This collaboration aims to adapt Wearable Devices' neural gesture technology for defense requirements, especially in situations where silent activation is crucial. The agreement includes provisions for joint developed proof of concept with a focus on providing field-tested, user-friendly solutions for defense personnel.

07:07 EST Paramount Gold Nevada closes $15M financing with Sprott Streamg - Paramount Gold Nevada has closed the previously announced $15 million financing with Sprott Resource and Streaming Royalty Corp., through the issuance of a non-dilutive Secured Royalty Convertible Note. The proceeds of the financing will be used to fund the continued permitting of the proposed Grassy Mountain Gold Mine in eastern Oregon, for general corporate purposes and for the repayment of the company's outstanding debt. The RCN will carry an interest rate of 10% per annum, which, at Paramount's discretion, will be payable in cash or shares at a 7% discount to the 10-day VWAP from the scheduled date of payment of interest. The RCN may be repaid in cash or through the issuance of the Royalty at the earlier of the commencement of commercial production or 5 years from the RCN closing date. The RCN is convertible into a gross revenue royalty of 4.75% of the gold and silver produced from the proposed Grassy Mountain Gold Mine proportionate to the final amount of the funds that have been advanced upon reaching commercial production. If a Royalty is issued, Paramount has the option to buy back 50% of the Royalty by paying either $11.25 million on the 2nd anniversary of the RCN agreement or $12.375 million on the 3rd anniversary.

07:06 EST CytoSorbents says STAR-T trial did not meet primary effectiveness endpoint - CytoSorbents announces an update on the initial data analysis of primary safety and effectiveness endpoints and the final independent Data and Safety Monitoring Board analysis for the pivotal U.S. and Canadian STAR-T randomized controlled trial. STAR-T is a double-blind, randomized, controlled, multi-center pivotal trial that investigated the ability of DrugSorb-ATR to reduce perioperative bleeding in 140 enrolled patients on ticagrelor undergoing cardiothoracic surgery before completing the recommended washout period. Patients were randomized in a 1:1 ratio to receive either DrugSorb-ATR or a sham device during cardiopulmonary bypass, with a primary composite effectiveness endpoint measuring perioperative bleeding. The independent DSMB met recently to perform the final review of the full unblinded data on all 140 patients in the STAR-T trial and concluded there were no issues with device safety, meeting the primary safety endpoint of the study. The Company has also performed the initial data analysis on the primary effectiveness endpoint of STAR-T. Based on this analysis, the study did not meet the primary effectiveness endpoint in the overall patient population that underwent different types of cardiac surgeries. However, the study did demonstrate evidence of reduced bleeding complications in patients in the pre-specified isolated coronary artery bypass graft surgery population, representing more than 90% of the overall study population. The Company expects to complete the analysis of the full trial results in the next several weeks. Pending this final analysis, the Company believes the safety and effectiveness data from STAR-T may support the regulatory submission of DrugSorb-ATR to the U.S. FDA and Health Canada. Meanwhile, the Company had previously submitted a promissory abstract to the American College of Cardiology 2024 conference, triggering a "silent" period for publicly discussing detailed study results. If accepted, the full results of the STAR-T trial are expected to be presented next April 2024 in Atlanta.

06:33 EST Ault's RiskOn International to announce generative AI platform in January - Ault Alliance announced that its majority beneficially owned subsidiary, RiskOn International expects to announce, on January 3, 2024, via a press release and various media outlets, its new generative artificial intelligence platform as well as unveil a relationship with its principal technology partner. This partnership represents a strategic collaboration with the technology partner, which has invested more than five years of research and development into the AI Platform. RiskOn's to-be-announced technology partner has been engaged in the realm of AI development since 2018. RiskOn expects to announce a full stack application built around large language model and jointly developed business applications expected to provide value for business owners of all sizes.

06:32 EST DouYu announces $20M share repurchase program - DouYu announced that its board of directors and management have authorized a share repurchase program under which the company may repurchase up to $20M of its ordinary shares in the form of American depositary shares during a period of up to twelve months commencing on January 1, 2024, subject to the relevant rules under the Securities Exchange Act of 1934, as amended.

06:06 EST Brunswick announces solar installations to global manufacturing facilities - Brunswick Corporation has announced the completion of solar installations at three of its global facilities including its first project in Mexico. Brunswick's Reynosa facility, which manufactures its award-winning Bayliner, Trophy, Heyday, Sea Ray, and Lund brands, has installed more than 900 photovoltaic solar panels covering 4,000 square meters on the roof of the facility. The installation is expected to cover approximately 45% of the annual energy consumed by the facility's assembly area and generate approximately 800,000 kWH of electricity per year. The new solar panels will result in the annual avoidance of an estimated 565 metric tons of carbon emissions. In addition to the new solar panels in Reynosa, the facility has also completed installation of a new osmosis wastewater recovery system, which will recycle wastewater within the plant and reduce annual water consumption by an estimated 10%. In continued pursuit of its goal to have 60% of its electricity from renewable sources by the end of 2025, Brunswick also announced that it is installing two new 100kW solar systems - one at its Mercury Marine Australian/New Zealand head office in Dandenong South and another at the company's BLA office in Murarrie, Brisbane. The Dandenong installation is projected to generate approximately 48 percent of the office's electricity needs, preventing 132 tons of CO2 from being released into the atmosphere annually. The Murarrie office solar system will on average meet 50% of the office's power demand and have the capability to supply 100% of power during peak times. The system will generate approximately 142,000 kilowatt hours of electricity annually, enough to power around 20 homes for a full year.

06:05 EST Comstock Mining executes first biorefinery commercial agreement - Comstock has executed agreements with RenFuel K2B AB to advance Comstock's first commercial biorefinery, including an option to acquire a subsidiary of RenFuel, or JV. The JV has previously completed preliminary engineering for a new biorefinery using RenFuel's patented catalytic esterification process to refine lignin from byproducts of paper production into a biointermediate for refining into sustainable aviation fuel and renewable diesel in Europe. Comstock also committed to a strategic $3M investment in RenFuel payable over the next three years for the continued development and commercialization of advanced applications of RenFuel's and Comstock's complimentary technologies. RenFuel granted Comstock the right to acquire a majority stake in the JV as part of the consideration paid under Comstock's investment. RenFuel and the JV have previously entered into agreements with a strategic investor with renewable fuel refining assets in Europe. The investor intends to make additional investments in increased renewable fuel capacity at some of its existing refineries. Comstock holds the exclusive license to RenFuel's refining technologies in North America, Central America, and South America.

06:03 EST Guild Mortgage lists first two 'Making Paradise Home' initiative houses - Guild Mortgage announced the first two homes from its Making Paradise Home Initiative are completed and listed for sale. The affordable, sustainable manufactured homes are available for sale in Paradise, California, the community hardest hit by the deadliest and most destructive wildfire in the state's history. In January 2023, Guild announced its Making Paradise Home Initiative in partnership with Clayton Homes, Golden West Homes of Chico and Redline Installation to build four CrossMod Homes to help educate residents about the benefits of manufactured housing, while helping to rebuild the community. Since the initiative's launch, two homes are now listed and available for sale. Both brand new CrossMod homes - located at 6249 Fern Lane and 5931 Debbie Lane in Paradise California - boast beautiful curb appeal, high-end quality and energy efficiency throughout. The homes sit on quiet lanes with circular driveways on over half an acre, each. Both 1,620-square-foot, three bedroom and two full bathroom homes feature a modern design including high ceilings; oversized windows; covered front porches; two-car garages; stylish fireplaces in the living rooms; quartz or granite kitchen countertops; shaker cabinets; farm-style sinks; large islands with seating; and farmhouse laminate flooring throughout. As CrossMod homes, buyers are eligible for unique financing with as little as a 3% down payment.

05:15 EST Astellas, Elpiscience enter license agreement for bi-specific macrophage engager - Elpiscience Biopharma and Astellas Pharma announced a research collaboration and license agreement for novel bi-specific macrophage engagers, ES019 and another program. The two companies will collaboratively conduct early-stage research for these two programs. Elpiscience will also grant Astellas the right to add up to two additional programs to be included in the collaboration. If Astellas exercises its option, Elpiscience will grant Astellas the exclusive right to further research, develop, manufacture and commercialize the products for each program.